Submissions for variant NM_001110792.2(MECP2):c.516_517del (p.Gly173fs) (rs267608486)

Minimum review status:		Collection method:
Minimum conflict level:
		ClinVar version:

Total submissions: 2

Download table as spreadsheet

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000255199	SCV000322255	pathogenic	not provided	2016-04-11	criteria provided, single submitter	clinical testing	The c.480_481delTG pathogenic variant in the MECP2 gene has been reported previously using alternate nomenclature 480del2 in an individual with atypical Rett syndrome (Weaving et al., 2003). The c.480_481delTG variant causes a frameshift starting with codon Glycine 161, changes this amino acid to a Glutamic Acid residue, and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Gly161GlufsX13. This variant is predicted to cause loss of normal protein function through protein truncation as the last 326 amino acids of the MECP2 protein are lost and replaced with 12 incorrect amino acids. The c.480_481delTG variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.480_481delTG as a pathogenic variant.
RettBASE	RCV000133133	SCV000188125	pathogenic	Rett syndrome	2002-04-05	no assertion criteria provided	curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.